BiotechTube

Avatrombopag + Placebo + Pegylated interferon (PEG-IFN) + Telaprevir + Ribavirin

Phase 2Completed
0 watching 0 views this week⚡ Active
52
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Thrombocytopenia

Conditions

Thrombocytopenia

Trial Timeline

Nov 1, 2011 → May 1, 2014

NCT ID
NCT01355289

About Avatrombopag + Placebo + Pegylated interferon (PEG-IFN) + Telaprevir + Ribavirin

Avatrombopag + Placebo + Pegylated interferon (PEG-IFN) + Telaprevir + Ribavirin is a phase 2 stage product being developed by Eisai for Thrombocytopenia. The current trial status is completed. This product is registered under clinical trial identifier NCT01355289. Target conditions include Thrombocytopenia.

Hype Score Breakdown

Clinical
17
Activity
12
Company
10
Novelty
5
Community
5

Clinical Trials (1)

NCT IDPhaseStatus
NCT01355289Phase 2Completed

Competing Products

20 competing products in Thrombocytopenia

See all competitors
ProductCompanyStageHype Score
Pirtobrutinib + PlaceboEli LillyPhase 1/2
41
Anti-(integrin beta-3) human monoclonal antibodyRallybioPhase 2
44
Placebo + LusutrombopagShionogiPhase 2
52
LusutrombopagShionogiPhase 2
52
Avatrombopag + Avatrombopag + PlaceboEisaiPhase 2
52
avatrombopagEisaiPhase 1
33
E5501 + Drug: E5501EisaiPhase 1
33
avatrombopag (lower baseline platelet count) + placebo (lower baseline platelet count) + avatrombopag (higher baseline platelet count) + placebo (higher baseline platelet count)EisaiPhase 3
77
avatrombopag + PlaceboEisaiPhase 2
52
avatrombopag (lower baseline platelet count) + placebo (lower baseline platelet count) + avatrombopag (higher baseline platelet count) + placebo (higher baseline platelet count)EisaiPhase 3
77
Avatrombopag + Placebo + Standard of careEisaiPhase 3
77
RomiplostimKyowa KirinPhase 1/2
41
Romiplostim + PlaceboKyowa KirinPhase 3
77
Romiplostim (AMG-531)Kyowa KirinPhase 2
52
Romiplostim and danazolKyowa KirinPhase 2
52
ONO-7746Ono PharmaceuticalPhase 1
33
Hetrombopag OlamineJiangsu Hengrui MedicinePhase 1
33
Hetrombopag Olamine + Hetrombopag Olamine ；Hetrombopag Olamine PlaceboJiangsu Hengrui MedicinePhase 3
77
Hetrombopag OlamineJiangsu Hengrui MedicinePhase 2
52
TPO-RA (Herombopag) + TPO-RA (Herombopag) and rhTPO(Recombinant human thrombopoietin)Jiangsu Hengrui MedicinePhase 2
52

Other Products from Eisai

MecobalaminApproved
85
MonteplaseApproved
85
E2020 + PlaceboApproved
85
Palonosetron 0.075 mg IV + Dexamethasone 10 mg IV + Promethazine 25 mg IVApproved
85
DonepezilApproved
85